Jan Kirsten, PhD, MBR

Jan Kirsten is Chief Business Officer at Partex.AI and an international healthcare executive with extensive experience spanning the pharmaceutical, biotechnology, and medical technology sectors. His work focuses on advancing innovation, commercialization, and strategic growth across healthcare and life sciences. Prior to joining Partex.AI, Jan served as Global Head of the Rare Tumor Business at SpringWorks Therapeutics and was a member of the Merck Healthcare Executive Board. During his tenure at Merck, he held several senior leadership positions, including President of Healthcare Italy & Malta, Senior Vice President and Global Head of the Fertility Franchise, and Head of Group Strategy. With a background spanning commercial leadership, business development, corporate strategy, and organizational transformation, Jan brings a unique perspective on how emerging technologies, data-driven innovation, and cross-sector collaboration can accelerate therapeutic discovery and improve patient outcomes. He holds advanced degrees in business and molecular biology and is recognized for building high-performing, inclusive, and future-ready organizations.